Log In
BCIQ
Print this Print this
 

citoplurikin (IRX-2)

  Manage Alerts
Collapse Summary General Information
Company IRX Therapeutics Inc.
DescriptionImmune system stimulant comprised of a set of naturally-derived cytokines
Molecular Target Not available
Mechanism of ActionImmune modulation
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationHead and neck cancer
Indication DetailsTreat head and neck cancer
Regulatory Designation U.S. - Fast Track (Treat head and neck cancer)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
Get a free BioCentury trial today